// App-Quantinova.ai

O36 : Validation of methods to enable national registration for rare autoimmune rheumatic diseases

Researchers

Presenter

  • Fiona A Pearce

Principal Investigators

  • Megan Rutter

  • Bridget Griffiths

  • Chetan Mukhtyar

  • Reem Al-Jayoussi

  • Richard A Watts

  • Jeanette Aston

  • Mary Bythell

  • Sarah Stevens

  • Peter C Lanyon

Medical Centers

  • Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom

  • Rheumatology, Nottingham University Hospitals NHS Trust, Nottingham, UNITED KINGDOM

  • Haematology, Newcastle upon Tyne NHS Foundation Trust, Newcastle

  • Rheumatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UNITED KINGDOM

  • Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester, UNITED KINGDOM

  • Rheumatology Department, Ipswich Hospital, Ipswich, UNITED KINGDOM

  • National Congenital Anomaly and Rare Disease Registration Service, Public Health England, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

  • Adult onset Still's disease

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Microscopic polyangiitis

  • Relapsing polychondritis

  • Polyarteritis nodosa

  • Takayasu arteritis

  • Kawasaki disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved